Affiliation:
1. Tuberculosis Research Unit, Beth Israel Deaconess Center
2. New England Regional Primate Research Center, Southboro, Massachusetts 01772
3. Harvard Medical School, Boston, Massachusetts 02215
Abstract
ABSTRACT
The mechanism by which human immunodeficiency virus (HIV)-
Mycobacterium tuberculosis
coinfection facilitates development of HIV-related tuberculosis is poorly characterized. Macaque models of simian immunodeficiency virus (SIV
mac
)-
Mycobacterium bovis
BCG coinfection were employed to explore the pathogenesis of AIDS virus-related tuberculosis. Following BCG coinfection, SIV (SIV)-infected macaques with high viral loads developed an SIV-related tuberculosis-like disease. This disease was characterized clinically by a syndrome of diarrhea, anorexia, weight loss, and altered levels of consciousness and pathologically by the presence of disseminated granulomas. In contrast, SIV
mac
-infected macaques with low viral loads either showed no evidence of BCG-induced disease or developed focal granulomatous lesions. Pathogenic SIV-BCG interactions appeared to play a critical role in triggering the development of this SIV-related tuberculosis-like disease. BCG coinfection enhanced the destruction of CD4
+
T cells in SIV
mac
-infected macaques whose viral loads were high. Reciprocally, exacerbations of SIV disease led to marked suppression of BCG-specific T-cell responses, persistence of the BCG infection, and development of an SIV-related tuberculosis-like disease. Furthermore, development of this SIV-related tuberculosis-like disease was also seen in naïve macaques simultaneously inoculated with SIV
mac
and BCG. These results provide in vivo evidence that coinfection of AIDS virus-infected individuals with an avirulent mycobacterium can lead to development of a tuberculosis-like disease.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference41 articles.
1. Barnes, P. F., A. B. Bloch, P. T. Davidson, and D. E. Snider. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med.324:1644–1650.
2. Boudes, P., A. Sobel, L. Deforges, and E. Leblic. 1989. Disseminated Mycobacterium bovis infection from BCG vaccination and HIV infection. JAMA262:2386.
3. Brett, J. L., and M. W. Humble. 1991. Incidence of human tuberculosis caused by Mycobacterium bovis. N. Z. Med. J.104:13–14.
4. Brindle, R. J., P. P. Nunn, W. Githui, B. W. Allen, S. Gathua, and P. Waiyaki. 1993. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am. Rev. Respir. Dis.147:958–961.
5. Casanova, J. L., E. Jouanguy, S. Lamhamedi, S. Blanche, and A. Fischer. 1995. Immunological conditions of children with BCG disseminated infection. Lancet346:581.